Elizabeth A. Morgan

6.2k total citations
93 papers, 2.5k citations indexed

About

Elizabeth A. Morgan is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Elizabeth A. Morgan has authored 93 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 28 papers in Pathology and Forensic Medicine and 24 papers in Hematology. Recurrent topics in Elizabeth A. Morgan's work include Lymphoma Diagnosis and Treatment (27 papers), Acute Myeloid Leukemia Research (16 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Elizabeth A. Morgan is often cited by papers focused on Lymphoma Diagnosis and Treatment (27 papers), Acute Myeloid Leukemia Research (16 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Elizabeth A. Morgan collaborates with scholars based in United States, Canada and United Kingdom. Elizabeth A. Morgan's co-authors include Lorraine S. Symington, Katherine N. Weilbaecher, Angela C. Hirbe, Sylvie Moreau, Özge Uluçkan, Geraldine S. Pinkus, Zuzana Tóthová, Alessandra F. Nascimento, Jon C. Aster and Julie L. Prior and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Elizabeth A. Morgan

89 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth A. Morgan United States 30 811 788 682 632 535 93 2.5k
Reiner Siebert Germany 34 871 1.1× 1.6k 2.0× 778 1.1× 1.5k 2.4× 244 0.5× 144 3.3k
Juan Luis Garcı́a Spain 29 984 1.2× 1.3k 1.6× 836 1.2× 806 1.3× 1.2k 2.3× 127 3.2k
Stefan K. Barta United States 23 1.1k 1.4× 439 0.6× 341 0.5× 1.1k 1.7× 170 0.3× 146 2.1k
Maria Christina Cox Italy 30 842 1.0× 850 1.1× 516 0.8× 743 1.2× 1.2k 2.3× 111 2.8k
Michael Møller Denmark 34 1.3k 1.6× 966 1.2× 1.0k 1.5× 1.6k 2.5× 440 0.8× 161 4.2k
Anne Uyttebroeck Belgium 27 734 0.9× 469 0.6× 398 0.6× 891 1.4× 402 0.8× 132 2.7k
Naoyoshi Mori Japan 25 650 0.8× 500 0.6× 334 0.5× 1.0k 1.6× 164 0.3× 111 2.2k
Adam J. Olszewski United States 28 1.3k 1.7× 539 0.7× 781 1.1× 1.3k 2.1× 193 0.4× 212 3.1k
Frank Hartmann Germany 25 910 1.1× 561 0.7× 319 0.5× 954 1.5× 514 1.0× 82 2.8k
Ulf Kristoffersson Sweden 33 745 0.9× 1.3k 1.6× 413 0.6× 935 1.5× 582 1.1× 156 4.2k

Countries citing papers authored by Elizabeth A. Morgan

Since Specialization
Citations

This map shows the geographic impact of Elizabeth A. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Morgan more than expected).

Fields of papers citing papers by Elizabeth A. Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth A. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Morgan. The network helps show where Elizabeth A. Morgan may publish in the future.

Co-authorship network of co-authors of Elizabeth A. Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth A. Morgan. A scholar is included among the top collaborators of Elizabeth A. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth A. Morgan. Elizabeth A. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, Waihay J., Rebecca L. Zon, Caleb Ho, et al.. (2025). Somatic mutations in STAG2 are associated with separated megakaryocyte nuclear lobes in myelodysplastic syndromes. Blood Advances. 9(20). 5283–5288.
2.
3.
Griffith, David, et al.. (2022). 217. A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of the Lipopeptide QPX9003 in Healthy Adult Subjects. Open Forum Infectious Diseases. 9(Supplement_2). 7 indexed citations
4.
Mpunga, Tharcisse, Gary M. Clifford, Elizabeth A. Morgan, et al.. (2021). Epstein‐Barr virus prevalence among subtypes of malignant lymphoma in Rwanda, 2012 to 2018. International Journal of Cancer. 150(5). 753–760. 4 indexed citations
5.
Suh, Chong Hyun, et al.. (2021). Imaging of IgG4-Related Disease in the Head and Neck: A Systematic Review, Case Series, and Pathophysiology Update. Journal of Neuroradiology. 48(5). 369–378. 12 indexed citations
6.
Nomburg, Jason, Susan Bullman, Katsuhiro Togami, et al.. (2020). Comprehensive metagenomic analysis of blastic plasmacytoid dendritic cell neoplasm. Blood Advances. 4(6). 1006–1011. 9 indexed citations
7.
Craig, Jeffrey W., Robert P. Hasserjian, Annette S. Kim, et al.. (2020). Detection of the KIT mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis. Modern Pathology. 33(6). 1135–1145. 12 indexed citations
8.
Lesch, Bluma J., Zuzana Tóthová, Elizabeth A. Morgan, et al.. (2019). Intergenerational epigenetic inheritance of cancer susceptibility in mammals. eLife. 8. 40 indexed citations
9.
Mito, Jeffrey K., Devarati Mitra, Constance M. Barysauskas, et al.. (2019). A Comparison of Outcomes and Prognostic Features for Radiation-Associated Angiosarcoma of the Breast and Other Radiation-Associated Sarcomas. International Journal of Radiation Oncology*Biology*Physics. 104(2). 425–435. 30 indexed citations
10.
Vedula, Rahul S., Marlise R. Luskin, Priti Kumari, et al.. (2018). Clinical Characteristics of GNB1 and GNAS Mutations in an Unselected Cohort of 6,343 Patients with Hematologic Abnormalities. Blood. 132(Supplement 1). 1819–1819. 2 indexed citations
11.
12.
Dorfman, David M., Elizabeth A. Morgan, Ashley K. Pelton, & Christine Unitt. (2017). T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiation. Human Pathology. 65. 166–174. 8 indexed citations
13.
Mason, Emily F., Elizabeth A. Morgan, Geraldine S. Pinkus, & Olga Pozdnyakova. (2017). Cost‐effective approach to the diagnostic workup of B cell lymphoproliferative disorders via optimal integration of flow cytometric data. International Journal of Laboratory Hematology. 39(2). 137–146. 2 indexed citations
14.
Tóthová, Zuzana, John M. Krill-Burger, Katerina D. Popova, et al.. (2017). Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia. Cell stem cell. 21(4). 547–555.e8. 63 indexed citations
15.
Elf, Shannon, Nouran S. Abdelfattah, Edwin Chen, et al.. (2016). Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation. Cancer Discovery. 6(4). 368–381. 189 indexed citations
16.
Lampson, Benjamin L., Siddha Kasar, Tiago R. Matos, et al.. (2016). Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity. Blood. 128(2). 195–203. 227 indexed citations
17.
Montero, Joan, Jason Stephansky, Tianyu Cai, et al.. (2016). Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax. Cancer Discovery. 7(2). 156–164. 144 indexed citations
18.
Hirbe, Angela C., Elizabeth A. Morgan, & Katherine N. Weilbaecher. (2010). The CXCR4/SDF-1 Chemokine Axis: A Potential Therapeutic Target for Bone Metastases?. Current Pharmaceutical Design. 16(11). 1284–1290. 57 indexed citations
19.
Wickremaratchi, Mirdhu, Yoav Ben‐Shlomo, Elizabeth A. Morgan, et al.. (2009). CLINICAL FEATURES OF YOUNG ONSET PARKINSON'S DISEASE. Journal of Neurology Neurosurgery & Psychiatry. 80. 106–106. 1 indexed citations
20.
Morgan, Elizabeth A., Naseem Shah, & Lorraine S. Symington. (2002). The Requirement for ATP Hydrolysis by Saccharomyces cerevisiae Rad51 Is Bypassed by Mating-Type Heterozygosity or RAD54 in High Copy. Molecular and Cellular Biology. 22(18). 6336–6343. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reiner Siebert Breakdown of academic impact, for papers by Juan Luis Garcı́a Breakdown of academic impact, for papers by Stefan K. Barta Breakdown of academic impact, for papers by Maria Christina Cox Breakdown of academic impact, for papers by Michael Møller Breakdown of academic impact, for papers by Anne Uyttebroeck Breakdown of academic impact, for papers by Naoyoshi Mori Breakdown of academic impact, for papers by Adam J. Olszewski Breakdown of academic impact, for papers by Frank Hartmann Breakdown of academic impact, for papers by Ulf Kristoffersson
Rankless by CCL
2026